Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical setting
S. D. Busslinger, A. K. Mapanao, K. Kegler, P. Bernhardt, F. Fluehmann, J. Fricke, J. R. Zeevaart, U. Koester, N. P. van der Meulen, R. Schibli, C. Mueller
This study compares the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in mice, finding that SSTR antagonists caused more hematologic changes than agonists, but both were safe at therapeutic activity levels.
bioRxiv · Mar 29, 2024 · PreprintCancer Biology